Marchou B, Tangre P, Charreau I, Izopet J, Girard PM, May T, Ragnaud JM, Aboulker JP, Molina JM; ANRS 106 study team. Intermittent antiretroviral therapy in patients with controlled HIV infection. AIDS. 2007, 21:457-66.Lien PubMed
Green
H, Gibb DM, Walker AS, Pillay D, Butler K, Candeias F,
Castelli-Gattinara G, Compagnucci A, Della Negra M, de Rossi A,
Feiterna-Sperling C, Giaquinto C, Harper L, Levy J, Saïdi Y, Wintergerst
U (Penta 5 trial).Lamivudine/abacavir maintains virological
superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5
years in children. AIDS 2007, 21:947-955. Lien PubMed
Durier
C, Capitant C, Lascaux AS, Goujard C, Oksenhendler E, Poizot-Martin I,
Viard JP, Weiss L, Netzer E, Delfraissy JF, Aboulker JP, and Lévy Y. Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048-079 Trials). AIDS 2007, 21:1887-97.Lien PubMed
Launay
O, Durier C, Desaint C, Silbermann B, Jackson A, Pialoux G, Bonnet B,
Poizot-Martin I, Gonzalez-Canali G, Cuzin L, Figuereido S, Surenaud M,
Ben Hamouda N, Gahery H, Choppin J, Salmon D, Guérin C, Bourgault
Villada I, Guillet JG, for the ANRS VAC16 Study Group. Cellular
Immune Responses Induced with Dose-Sparing Intradermal Administration
of HIV Vaccine to HIV-Uninfected Volunteers in the ANRS VAC16 Trial. PLoS One 2007, 2(8):e725.Lien PubMed
Goujard
C, Marcellin F, Hendel-Chavez H, Burgard M, Meiffrédy V, Venet A,
Rouzioux C, Taoufik Y, El Habib R, Beumont-Mauviel M, Aboulker JP, Lévy
Y, and Delfraissy JF for the PRIMOVAC-ANRS 095 Study Group.Interruption
of antiretroviral therapy initiated during primary HIV-1 infection:
impact of a therapeutic vaccination strategy combined with interleukin
(IL)-2 compared with IL-2 alone in the ANRS 095 randomized study. AIDS Res and Hum Retroviruses 2007, 23(9):1105-13. Lien PubMed
Gérard L, Chazallon C, Taburet AM, Girard PM, Aboulker JP, Piketty C.Renal
function in antiretroviral-experienced patients treated with tenofovir
disoproxil fumarate associated with atazanavir/ritonavir. Antiviral Therapy 2007, 12(1):31-39.Lien PubMed
Launay
O, Durier C, Desaint C, Silbermann B, Jackson A, Pialoux G, Bonnet B,
Poizot-Martin I, Gonzalez-Canali G, Cuzin L, Figuereido S, Surenaud M,
Ben Hamouda N, Gahery H, Choppin J, Salmon D, Guérin C, Bourgault
Villada I, Guillet JG, for the ANRS VAC16 Study Group . Cellular
Immune Responses Induced with Dose-Sparing Intradermal Administration
of HIV Vaccine to HIV-Uninfected Volunteers in the ANRS VAC16 Trial. PLoS One 2007, 2(8):e725.Lien PubMed